Reverse transcriptase-polymerase chain reaction to evaluate human cytomegalovirus lytic gene expression

Molecular Biotechnology

Volumn 40, Issue 2, 2008, Pages 144-150

  Bergallo, Massimiliano ^a   Costa, Cristina ^a   Terlizzi, Maria Elena ^a   Margio, Samuela ^a   Sidoti, Francesca ^a   Astegiano, Sara ^a   Sinesi, Franca ^a   Cavallo, Rossana ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

HCMV; Lytic gene expression; RT PCR; UL123; UL54; UL65

Indexed keywords

ABS RESINS; BIOACTIVITY; COSMIC RAYS; POLYMERIZATION; PUMPS;

HCMV; LYTIC GENE EXPRESSION; RT-PCR; UL123; UL54; UL65;

GENE EXPRESSION;

VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNOCOMPROMISED PATIENT; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UL123 GENE; UL54 GENE; UL65 GENE; VIRUS GENE; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION, VIRAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HUMAN HERPESVIRUS 5;

EID: 56749164603     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-008-9070-7     Document Type: Article

References (20)

1. S Landolfo M Gariglio G Gribaudo D Lembo 2003 The human cytomegalovirus Pharmacology and Therapeutics 98 269 297 10.1016/S0163-7258(03)00034-2
2. T Reischig P Jindra M Svecova S Kormunda K Opatrny Jr V Treska 2006 The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection Journal of Clinical Virology 36 146 151 10.1016/j.jcv.2006. 01.015
3. M Bergallo C Costa ME Terlizzi 2008 Evaluation of two set of primers for detection of immediate early gene UL123 of human Cytomegalovirus (HCMV) Molecular Biotechnology 38 65 70 10.1007/s12033-007-0074-5
4. M Bergallo C Costa S Tarallo 2006 Development of a quantitative- competitive PCR for quantification of HCMV load and comparison with antigenaemia, viraemia and pp67 RNA detection by NASBA Panminerva Medica 48 119 127
5. T Cihlar MD Fuller JM Cherrington 1998 Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments Journal of Virology 72 5927 5936
6. S Larson C Soderberg-Naucler FZ Wang E Moller 1998 Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time Transfusion 38 271 278 10.1046/j.1537-2995.1998.38398222871.x
7. RL Saltzman MR Quirk MC Jordan 1992 High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients The Journal of Clinical Investigation 90 1832 1838 10.1172/JCI116059
8. J Gozlan JP Laporte S Lesage 1996 Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse-transcription-PCR and blood and urine culture Journal of Clinical Microbiology 34 2085 2088
9. U Meyer-Koenig I Romberg K Schneider M Weidmann WV Kern FT Hufert 2006 Diagnostic value of reverse transcription-PCR for detection of cytomegalovirus pp67 in samples from solid-organ transplant recipients Journal of Clinical Microbiology 44 3394 3396 10.1128/JCM.00493-06
10. KMC Lam N Oldenburg MA Khan 1998 Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients The Journal of Heart and Lung Transplantation 17 555 565
11. U Meyer-Koning A Serr D von Laer 1995 Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: Diagnostic value in renal transplant recipients The Journal of Infectious Diseases 171 705 709
12. PN Nelson BK Kawal YS Boriskin 1996 A polymerase chain reaction to detect a spliced late transcripts of human cytomegalovirus in the blood of bone marrow transplant recipients Journal of Virological Methods 56 139 148 10.1016/0166-0934(95)01900-6
13. N Oldenburg KMC Lan B Top 2000 Monitoring of CMV immediate early, early and late gene expression as prognostic markers of CMV disease in thoracic organ transplant recipients using NASBA Transplantation 70 1209 1215 10.1097/00007890-200010270-00015
14. YS Boriskin K Fuller RL Powles 2002 Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: A two site evaluation Journal of Clinical Virology 24 13 23 10.1016/S1386-6532(01)00209-8
15. T Allice M Enrietto F Pittaluga 2006 Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: Comparison with end-point PCR and pp65 antigen test Journal of Medical Virology 78 915 922 10.1002/jmv.20641
16. D Lilleri G Gerna M Furione 2007 Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of pre-emptively treated children and young adults receiving haematopoietic stem cell transplantation as compared to qualitative pp65-antigenemia Blood 110 2757 2760 10.1182/blood-2007-03-080820
17. DJ Kim SJ Kim J Park 2007 Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients Transplantation Proceedings 39 1458 1460 10.1016/j.transproceed.2007.01.088
18. G Boivin N Goyette C Gilbert A Humar E Covington 2005 Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients Transplant Infectious Disease 7 166 170 10.1111/j.1399-3062.2005.00112. x
19. E Nogueira KS Ozaki H Tomiyama CF Granato NO Camara A Pacheco-Silvia 2006 The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients International Immunopharmacology. 20 2031 2037 10.1016/j.intimp. 2006.07.022
20. GM Scott MA Isaacs F Zeng AM Kesson WD Rawlinson 2004 Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein Kinase) and UL54 (DNA polymerase) mutations Journal of Medical Virology 74 85 93 10.1002/jmv.20150